John Hancock Variable Insurance Trust - Health Sciences Trust (JAFKX)

Fund Assets	n/a
Expense Ratio	1.24%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	3.23
Dividend Yield	14.71%
Dividend Growth	89.39%
Payout Frequency	Annual
Ex-Dividend Date	Oct 23, 2025

Previous Close	22.21
YTD Return	16.98%
1-Year Return	16.98%
5-Year Return	n/a
52-Week Low	17.17
52-Week High	22.54
Beta (5Y)	n/a
Holdings	175
Inception Date	n/a

About JAFKX

John Hancock Variable Insurance Trust Health Sciences Trust Series II is an investment fund designed primarily for use within variable insurance products. Its central purpose is to provide investors with exposure to the healthcare and life sciences sectors by investing in equity securities of companies involved in health sciences, including pharmaceuticals, biotechnology, healthcare equipment, and services. The fund targets companies with durable and niche business models that are positioned to deliver high returns on capital, often focusing on mid- to large-cap firms with established market capitalizations and strong growth prospects. Employing a bottom-up stock selection approach, the fund's management emphasizes fundamental analysis to identify undervalued opportunities within the sector. Its role in the financial market is to offer diversification for investors seeking concentrated healthcare exposure within the broader context of insurance-linked investments, helping balance portfolio risk while capitalizing on innovation and demographic trends driving the health sciences industry. The fund is actively managed and reflects John Hancock’s commitment to sector-specific investment strategies within variable insurance trusts.

• Stock Exchange: NASDAQ
• Ticker Symbol: JAFKX
• Share Class: Series II
• Index: S&P 500 TR

Performance

JAFKX had a total return of 16.98% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.77%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
JAFMX	Nav	0.99%
JEHSX	Series I	1.04%

Top 10 Holdings

39.95% of assets

Name	Symbol	Weight
Eli Lilly and Company - ELI LILLY and CO COMMON STOCK	LLY.US	10.20%
Thermo Fisher Scientific Inc. - THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0	TMO.US	4.12%
Intuitive Surgical Inc. - INTUITIVE SURGICAL INC COMMON STOCK USD.001	ISRG.US	3.71%
Stryker Corporation - STRYKER CORP COMMON STOCK USD.1	SYK.US	3.52%
Merck and Co. Inc. - MERCK and CO INC COMMON STOCK USD.5	MRK.US	3.48%
ASTRAZENECA PLC COMMON STOCK USD.25	AZN.US	3.22%
UnitedHealth Group Incorporated - UNITEDHEALTH GROUP INC COMMON STOCK USD.01	UNH.US	3.13%
ARGENX SE ADR	ARGX.US	2.99%
AbbVie Inc. - ABBVIE INC COMMON STOCK USD.01	ABBV.US	2.88%
Regeneron Pharmaceuticals Inc. - REGENERON PHARMACEUTICALS INC COMMON STOCK USD.001	REGN.US	2.69%

Dividend History

Ex-Dividend	Amount	Pay Date
Oct 23, 2025	$3.23399	Oct 24, 2025
Oct 24, 2024	$1.70757	Oct 25, 2024
Oct 24, 2023	$1.26206	Oct 25, 2023
Oct 25, 2022	$3.23984	Oct 26, 2022

Data Sources: Tiingo and Finnhub

Historical data is provided by Tiingo. Several fund data points are also provided by Finnhub.

Last checked:

Aug 28, 2026

Data Sources Report a data error